Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation -- a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study)

Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation -- a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study)

<p>Abstract</p> <p>Background</p> <p>Rapid conversion of atrial fibrillation (AF) to sinus rhythm may be achieved by the administration of class IA, IC and III antiarrhythmic drugs or vernakalant hydrochloride. However, that treatment may be related to potential pro-arr...

Full description

Bibliographic Details
Main Authors: Farkowski Michal M, Maciag Aleksander, Dabrowski Rafal, Pytkowski Mariusz, Kowalik Ilona, Szwed Hanna
Format: Article
Language:English
Published: BMC 2012-09-01
Series:Trials
Subjects:
Antazoline
Atrial fibrillation
Pharmacological cardioversion
Efficacy
Safety
Randomized clinical trial
Online Access:http://www.trialsjournal.com/content/13/1/162

Similar Items

Similar Items